Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.

[1]  J. Li,et al.  Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists. , 2008, Bioorganic & medicinal chemistry letters.

[2]  G. Marshall,et al.  Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor. , 2008, Biochemistry.

[3]  P. Monk,et al.  Function, structure and therapeutic potential of complement C5a receptors , 2007, British journal of pharmacology.

[4]  K. Zareba.  Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria. , 2007, Drugs of today.

[5]  K. Schnatbaum,et al.  Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity. , 2006, Bioorganic & medicinal chemistry letters.

[6]  T. Woodruff,et al.  Recent developments in C5/C5a inhibitors , 2006 .

[7]  M. Mizuno,et al.  Novel C5a regulators in inflammatory disease , 2005, Expert opinion on investigational drugs.

[8]  A. Higginbottom,et al.  Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site* , 2005, Journal of Biological Chemistry.

[9]  John D Lambris,et al.  Synthetic small-molecule complement inhibitors. , 2004, Current opinion in investigational drugs.

[10]  H. Sumichika.  C5a receptor antagonists for the treatment of inflammation. , 2004, Current opinion in investigational drugs.

[11]  H. Sumichika,et al.  Identification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist* , 2002, The Journal of Biological Chemistry.

[12]  Elaine C. Meng,et al.  An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.

[13]  J. Krause,et al.  The Discovery of Small Molecule C5a Antagonists , 2004 .